Correction: Fracture and mortality outcomes by osteoporosis treatment route in patients with type 2 diabetes and obesity: a propensity-matched registry study - Summary - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Correction: Outcomes of Fractures and Mortality Based on Osteoporosis Treatment Approaches in Obese Patients with Type 2 Diabetes: A Propensity-Matched Registry Analysis
To correct errors in references related to osteoporosis treatment outcomes in obese patients with type 2 diabetes.
Key Findings:
Several references were cited incorrectly in the original article.
Corrections include accurate journal names, volume, issue numbers, and DOI links.
Interpretation:
The corrections enhance the reliability of the study's citations, ensuring that readers can access the correct sources for further information.
Limitations:
The article does not provide new data or findings; it solely addresses citation errors.
Conclusion:
Accurate referencing is crucial for the credibility of scientific literature, and this correction serves to uphold the integrity of the original study.
In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.
